International Journal of Antimicrobial Agents
Volume 35, Issue 4 , Pages 375-381, April 2010

Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates—a multicentre, observational survey in critically ill patients

  • Dirk Vogelaers

      Affiliations

    • General Internal Medicine & Infectious Diseases, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
  • ,
  • David De Bels

      Affiliations

    • Intensive Care Department, Brugmann University Hospital, Brussels, Belgium
  • ,
  • Frédéric Forêt

      Affiliations

    • Department of Internal Medicine – Intensive Care Unit, CHR St. Joseph-Warquignies, Boussu, Belgium
  • ,
  • Sophie Cran

      Affiliations

    • Intensive Care Department, CHIREC, Brussels, Belgium
  • ,
  • Eric Gilbert

      Affiliations

    • Intensive Care Department, CHR du Tournaisis, Tournai, Belgium
  • ,
  • Karen Schoonheydt

      Affiliations

    • Intensive Care Department, Ziekenhuisnetwerk Antwerpen, Antwerp, Belgium
  • ,
  • Stijn Blot

      Affiliations

    • General Internal Medicine & Infectious Diseases, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 9 332 62 16.
  • ,
  • for the ANTHICUS Study Investigators

      Affiliations

    • The ANTHICUS Study Investigators are: O. Abid (RHMS, Ath, Belgium), S. Cran (CHIREC, Brussels, Belgium), D. De Bels (CHU Brugmann, Brussels, Belgium), F. De Leener (CHR St. joseph-Warquignies, Boussu, Belgium), L. Finianos (Clinique St. Joseph, Liège, Belgium), F. Forêt (CHR St. Joseph-Warquignies, Mons, Belgium), M. Genard (CIU Ambroise Paré, Mons, Belgium), E. Gilbert (CHR du Tournaisis, Tournai, Belgium), E. Khodadadi (IRIS Sud-Bracops, Brussels, Belgium), S. Machayekhi (CH Hornu Frameries, Hornu), D. Mircev (IRIS Sud-Etterbeek-Ixelles, Brussels, Belgium), D. Neuberg (CH de L’Ardenne, Libramont, Belgium), J.-Y. Piette (CH Bois de l’Abbaye, Seraign, Belgium), P. Serpe (CH ND Bruyères, Chenee, Belgium), F. Beernaert (H. Hart Ziekenhuis, Eeklo, Belgium), K. De Decker (Antwerp University Hospital, Antwerp, Belgium), K. De Ridder (AZ Maria Middelares, Sint-Niklaas, Belgium), C. Declercq (St. Josef Ziekenhuis, Izegem, Belgium), I. Demeyer (OLV Aalst, Aalst, Belgium), B. Nonneman (ASZ, Aalst, Belgium), K. Schoonheydt (ZNA, Antwerp, Belgium, W. Swinnen (AZ St. Blasius, Dendermonde, Belgium), and L. Wosteyn (ASZ, Roeselaere, Belgium).

Received 17 September 2009; accepted 23 November 2009. published online 01 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-8579(09)00549-4

doi:10.1016/j.ijantimicag.2009.11.015

International Journal of Antimicrobial Agents
Volume 35, Issue 4 , Pages 375-381, April 2010